Castro, Meredith
Wilkinson, Samuel T.
Al Jurdi, Rayan K.
Petrillo, Mary Pat
Zaki, Naim
Borentain, Stephane
Fu, Dong Jing
Turkoz, Ibrahim
Sun, Liping
Brown, Brianne
Cabrera, Patricia
Funding for this research was provided by:
Janssen Scientific Affairs, LLC
Article History
Accepted: 2 July 2023
First Online: 9 August 2023
Declarations
:
: This research was supported by Janssen Scientific Affairs, LLC.
: Samuel Wilkinson discloses receiving contract research funding from Janssen, Oui Therapeutics, and Sage Therapeutics for the conduct of clinical trials (administered through Yale University); he also discloses receiving consulting fees from Janssen, Oui Therapeutics, and Sage Therapeutics. Meredith Castro, Mary Pat Petrillo, Brianne Brown, and Patricia Cabrera are employees of Janssen Scientific Affairs, LLC, and hold stock in Johnson & Johnson, Inc. Naim Zaki, Stephane Borentain, Dong Jing Fu, and Ibrahim Turkoz are employees of Janssen Research & Development, LLC, and hold stock in Johnson & Johnson, Inc. Rayan Al Jurdi receives research funding from Janssen Pharmaceuticals, Inc. and Neurolief, Inc. and also serves on the Treatment Resistant Depression (TRD) Speaker Bureau, which is financially supported by Janssen Pharmaceuticals, Inc. Liping Sun is an employee of Cytel, Inc.
: This study (ClinicalTrials.gov identifier: NCT02782104) was approved by Independent Ethics Committees or Institutional Review Boards. This study was conducted in accordance with the ethical principles that have their origin in the Declaration of Helsinki and that are consistent with Good Clinical Practices and applicable regulatory requirements.
: All patients signed informed consent for participation in this study.
: Not applicable.
: The data sharing policy of Janssen Pharmaceutical Companies of Johnson & Johnson is available at ExternalRef removed. As noted on this site, requests for access to the study data can be submitted through Yale Open Data Access (YODA) Project site at ExternalRef removed.
: Not applicable.
: Conceptualization: SW, MC, SB, DJF, IT. Methodology: SW, MC, SB, DJF, IT, LS, BB. Software: IT, LS. Validation: IT, LS. Formal analysis: NZ, IT, LS. Investigation: RAJ, MC, DJF. Resources/funding acquisition: MC. Data curation: MC, IT. Writing, reviewing, and editing: SW, RAJ, MC, MPP, NZ, SB, DJF, IT, LS, BB, PC. Visualization: MC, IT. Supervision/project administration: MC. All authors contributed to drafting several versions of the manuscript and revised it critically for important intellectual content, have read and approved the final submitted manuscript, and agree to be accountable for the work.